Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Vascular Surgery

  Free Subscription


Articles published in J Am Coll Cardiol

Retrieve available abstracts of 199 articles:
HTML format



Single Articles


    March 2024
  1. ZIERATH R, Shah AM
    Reply: Aging in Patients With Fontan Circulation: Raison d'etre of Right Ventricle.
    J Am Coll Cardiol. 2024;83:e119.
    PubMed    


  2. MURAKAMI T
    Aging in Patients With Fontan Circulation: Raison d'etre of Right Ventricle.
    J Am Coll Cardiol. 2024;83:e117.
    PubMed    


  3. BATCHELOR WB, Damluji AA
    Rehospitalization After PCI vs CABG for Left Main Disease: Refocusing Our Lens.
    J Am Coll Cardiol. 2024;83:1082-1084.
    PubMed    


  4. KOSMIDOU I, Shahim B, Dressler O, Redfors B, et al
    Incidence, Predictors, and Impact of Hospital Readmission After Revascularization for Left Main Coronary Disease.
    J Am Coll Cardiol. 2024;83:1073-1081.
    PubMed     Abstract available


  5. BRIGUORI C, Quintavalle C, Mariano E, D'Agostino A, et al
    Kidney Injury After Minimal Radiographic Contrast Administration in Patients With Acute Coronary Syndromes.
    J Am Coll Cardiol. 2024;83:1059-1069.
    PubMed     Abstract available


  6. SCHWANN TA, Engelman DT
    Anemia and Sex Disparity in CABG Mortality: In Search of a Grand Unified Theory.
    J Am Coll Cardiol. 2024;83:929-931.
    PubMed    


  7. HARIK L, Habib RH, Dimagli A, Rahouma M, et al
    Intraoperative Anemia Mediates Sex Disparity in Operative Mortality After Coronary Artery Bypass Grafting.
    J Am Coll Cardiol. 2024;83:918-928.
    PubMed     Abstract available


  8. MUKHERJEE D
    Is There a Role for Routine Stress Testing After Multivessel or Left Main PCI?
    J Am Coll Cardiol. 2024;83:901-903.
    PubMed    


  9. LEE JM, Kim H, Park YS, Jo HH, et al
    Surveillance Stress Testing After Percutaneous Intervention for Patients With Multivessel or Left Main Coronary Disease.
    J Am Coll Cardiol. 2024;83:890-900.
    PubMed     Abstract available


    February 2024
  10. KIM YY, Hoteit MA
    Turning to "Omics" in Understanding Fontan-Associated Liver Disease.
    J Am Coll Cardiol. 2024;83:739-740.
    PubMed    


  11. BRAVO-JAIMES K, Wu X, Reardon LC, Lluri G, et al
    Intrahepatic Transcriptomics Differentiate Advanced Fibrosis and Clinical Outcomes in Adults With Fontan Circulation.
    J Am Coll Cardiol. 2024;83:726-738.
    PubMed     Abstract available


  12. DIMAIO JM, McCullough KA, Widmer RJ
    A Post Hoc Analysis of ISCHEMIA: Are All Events Created Equal?
    J Am Coll Cardiol. 2024;83:559-561.
    PubMed    


    January 2024
  13. STONE GW, Ali ZA, Hochman JS, Maron DJ, et al
    REPLY: Interpreting the Impact of Complete Revascularization in the ISCHEMIA Trial.
    J Am Coll Cardiol. 2024;83:e39-e40.
    PubMed    


  14. GUYTON RA, Halkos ME
    Benefit of Complete Anatomic Revascularization in ISCHEMIA: Reprise of a Familiar Theme.
    J Am Coll Cardiol. 2024;83:e37.
    PubMed    


  15. DIMITRIADIS K, Pyrpyris N, Tsioufis K
    Functional vs Anatomical Complete Revascularization: Is There an "ISCHEMIA" of FFR?
    J Am Coll Cardiol. 2024;83:e35.
    PubMed    


  16. HIRUMA T, Kitamura M, Takamisawa I, Izumi Y, et al
    Predictors of Repeated Septal Reduction After Alcohol Septal Ablation in Patients With Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2024;83:546-548.
    PubMed    


  17. CAPODANNO D, Spagnolo M
    Optical Coherence Tomography or Intravascular Ultrasound for Complex PCI: Different Approaches, Similar Outcomes.
    J Am Coll Cardiol. 2024;83:414-416.
    PubMed    


  18. BATES ER
    Clinically Significant Differences Between P2Y(12) Inhibitor Monotherapy and Aspirin Monotherapy Have Yet to Be Demonstrated.
    J Am Coll Cardiol. 2024;83:e9-e10.
    PubMed    


  19. TEHRANI BN, Batchelor WB, Spinosa D
    High-Risk Acute Pulmonary Embolism: Where Do We Go From Here?
    J Am Coll Cardiol. 2024;83:44-46.
    PubMed    


  20. BELLEMAIN-APPAIX A, Montalescot G
    Clopidogrel for Long-Term Secondary Prevention After Coronary Artery Stenting.
    J Am Coll Cardiol. 2024;83:32-34.
    PubMed    


    December 2023
  21. GRINES CL, DuPont A
    Lesion Selection and Optimizing PCI: Intravascular Hemodynamics, Imaging, or Both?
    J Am Coll Cardiol. 2023;82:2177-2178.
    PubMed    


  22. KUNO T, Kiyohara Y, Maehara A, Ueyama HA, et al
    Comparison of Intravascular Imaging, Functional, or Angiographically Guided Coronary Intervention.
    J Am Coll Cardiol. 2023;82:2167-2176.
    PubMed     Abstract available


    November 2023
  23. PAI RG
    Potential Mechanisms of Troponin Release in Stable Coronary Artery Disease.
    J Am Coll Cardiol. 2023;82:e215.
    PubMed    


  24. KURLANSKY PA, Bittl JA
    Learning From Machines to Predict Mortality After Surgical or Percutaneous Revascularization.
    J Am Coll Cardiol. 2023;82:2125-2127.
    PubMed    


  25. NINOMIYA K, Kageyama S, Shiomi H, Kotoku N, et al
    Can Machine Learning Aid the Selection of Percutaneous vs Surgical Revascularization?
    J Am Coll Cardiol. 2023;82:2113-2124.
    PubMed     Abstract available


  26. WERESKI R, Chapman AR, Mills NL
    Reply: Potential Mechanisms of Troponin Release in Stable Coronary Artery Disease.
    J Am Coll Cardiol. 2023;82:e217.
    PubMed    


  27. BARRABES JA, Rodenas-Alesina E, Mila L
    Delineating the Benefits of an Invasive Strategy in Octogenarians With Non-ST-Segment Elevation Acute Coronary Syndromes.
    J Am Coll Cardiol. 2023;82:2031-2033.
    PubMed    


  28. REDFORS B, Stone GW, Alexander JH, Bates ER, et al
    Outcomes According to Coronary Revascularization Modality in the ISCHEMIA Trial.
    J Am Coll Cardiol. 2023 Nov 8:S0735-1097(23)07988.
    PubMed     Abstract available


    October 2023
  29. WATANABE H, Morimoto T, Natsuaki M, Yamamoto K, et al
    Clopidogrel versus Aspirin Monotherapy Beyond 1 Year After PCI: STOPDAPT-2 5-Year Results.
    J Am Coll Cardiol. 2023 Oct 18:S0735-1097(23)07750.
    PubMed     Abstract available


  30. YANG S, Kang J, Park KW, Hur SH, et al
    Comparison of Antiplatelet Monotherapies After Percutaneous Coronary Intervention According to Clinical, Ischemic, and Bleeding Risks.
    J Am Coll Cardiol. 2023;82:1565-1578.
    PubMed     Abstract available


  31. ORTEGA-PAZ L, Sabate M, Angiolillo DJ
    Long-Term Clopidogrel Monotherapy After Percutaneous Coronary Intervention: Will the Pupil Surpass the Master?
    J Am Coll Cardiol. 2023;82:1579-1582.
    PubMed    


  32. KANG DY, Ahn JM, Yun SC, Hur SH, et al
    Guiding Intervention for Complex Coronary Lesions by Optical Coherence Tomography or Intravascular Ultrasound.
    J Am Coll Cardiol. 2023 Oct 17:S0735-1097(23)07816.
    PubMed     Abstract available


  33. ARGO MB, Barron DJ, Eghtesady P, Yerebakan C, et al
    Outcomes After Hybrid Palliation for Infants With Critical Left Heart Obstruction.
    J Am Coll Cardiol. 2023;82:1427-1441.
    PubMed     Abstract available


    September 2023
  34. POLZL L, Engler C, Sterzinger P, Lohmann R, et al
    Association of High-Sensitivity Cardiac Troponin T With 30-Day and 5-Year Mortality After Cardiac Surgery.
    J Am Coll Cardiol. 2023;82:1301-1312.
    PubMed     Abstract available


  35. STONE GW, Ali ZA, O'Brien SM, Rhodes G, et al
    Impact of Complete Revascularization in the ISCHEMIA Trial.
    J Am Coll Cardiol. 2023;82:1175-1188.
    PubMed     Abstract available


  36. THRANE PG, Olesen KKW, Thim T, Gyldenkerne C, et al
    Mortality Trends After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2023;82:999-1010.
    PubMed     Abstract available


    August 2023
  37. NAYAK A, Hall SA, Uriel N, Goldstein DJ, et al
    Predictors of 5-Year Mortality in Patients Managed With a Magnetically Levitated Left Ventricular Assist Device.
    J Am Coll Cardiol. 2023;82:771-781.
    PubMed     Abstract available


  38. MENDIETA G, Mehta S, Baber U, Angiolillo DJ, et al
    Bleeding and Ischemic Risks of Ticagrelor Monotherapy After Coronary Interventions.
    J Am Coll Cardiol. 2023;82:687-700.
    PubMed     Abstract available


  39. FANG J, Liu Y, Zhu Y, Li R, et al
    First-in-Human Transapical Beating-Heart Septal Myectomy in Patients With Hypertrophic Obstructive Cardiomyopathy.
    J Am Coll Cardiol. 2023;82:575-586.
    PubMed     Abstract available


  40. LEE SJ, Joo JH, Park S, Kim C, et al
    Combination Lipid-Lowering Therapy in Patients Undergoing Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2023;82:401-410.
    PubMed     Abstract available


    July 2023
  41. AHMAD Y, Velazquez EJ
    The Interplay of Complete Revascularization and Angina: More Is More?
    J Am Coll Cardiol. 2023;82:314-316.
    PubMed    


  42. CAO L, Zhang H, Ge Y, Guo W, et al
    Avoiding Stroke in Patients Undergoing Endovascular Aortic Arch Repair: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;82:265-277.
    PubMed     Abstract available


  43. GRAGNANO F, Cao D, Pirondini L, Franzone A, et al
    P2Y(12) Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events.
    J Am Coll Cardiol. 2023;82:89-105.
    PubMed     Abstract available


  44. KUMBHANI DJ, de Lemos JA
    The Optimal Antiplatelet Agent for Secondary Prevention of Coronary Artery Disease: Ring Out the Old?
    J Am Coll Cardiol. 2023;82:106-108.
    PubMed    


    June 2023
  45. GARTENBERG AJ, Krishnamurthy G, Srinivasan A, Escobar FA, et al
    Intrahepatic and Periduodenal Embolization for Protein-Losing Enteropathy Patients With Congenital Heart Disease.
    J Am Coll Cardiol. 2023;81:2476-2478.
    PubMed    


  46. ABDULKARIM A, Shaji S, Elfituri M, Gunsaulus M, et al
    Pulmonary Complications in Patients With Fontan Circulation: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;81:2434-2444.
    PubMed     Abstract available


  47. DAUERMAN HL
    Primary PCI, Thrombus, and COVID-19: Remembrance of Things Past.
    J Am Coll Cardiol. 2023;81:2417-2419.
    PubMed    


  48. RATHOD KS, Teoh Z, Tyrlis A, Choudry FA, et al
    Thrombus Burden and Outcomes in Patients With COVID-19 Presenting With STEMI Across the Pandemic.
    J Am Coll Cardiol. 2023;81:2406-2416.
    PubMed     Abstract available


  49. SIMARD T, Sarma D, Miranda WR, Jain CC, et al
    Pathogenesis, Evaluation, and Management of Pulmonary Vein Stenosis: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;81:2361-2373.
    PubMed     Abstract available


  50. GRAGNANO F, Mehran R, Calabro P, Valgimigli M, et al
    Reply: DAPT Shortening After Complex PCI: Examining the Fine Print.
    J Am Coll Cardiol. 2023;81:e193.
    PubMed    


  51. APOSTOLOS A, Vasilagkos G, Toutouzas K, Tsigkas G, et al
    DAPT Shortening After Complex PCI: Examining the Fine Print.
    J Am Coll Cardiol. 2023;81:e191.
    PubMed    


  52. STOUT K, Buber J
    The Last Stage of the Fontan Operation?
    J Am Coll Cardiol. 2023;81:2172-2174.
    PubMed    


  53. LEWIS MJ, Reardon LC, Aboulhosn J, Haeffele C, et al
    Morbidity and Mortality in Adult Fontan Patients After Heart or Combined Heart-Liver Transplantation.
    J Am Coll Cardiol. 2023;81:2161-2171.
    PubMed     Abstract available


  54. LEWIS MJ, Reardon LC, Aboulhosn J, Haeffele C, et al
    Clinical Outcomes of Adult Fontan-Associated Liver Disease and Combined Heart-Liver Transplantation.
    J Am Coll Cardiol. 2023;81:2149-2160.
    PubMed     Abstract available


    May 2023
  55. STONE GW, Gaudino M
    Reconsidering the Direction of Coronary Revascularization Trials.
    J Am Coll Cardiol. 2023;81:1974-1978.
    PubMed    


  56. KANJI R, Gue YX, Memtsas V, Spencer NH, et al
    Biomarkers of Thrombotic Status Predict Spontaneous Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2023;81:1918-1932.
    PubMed     Abstract available


  57. STONE GW, Kereiakes DJ, Gori T, Metzger DC, et al
    Five-Year Clinical Outcomes After Coronary Bioresorbable Scaffolds and Drug-Eluting Stents: The ABSORB IV Randomized Trial.
    J Am Coll Cardiol. 2023 May 13:S0735-1097(23)05527.
    PubMed     Abstract available


    April 2023
  58. HAGER A
    Invasive Cardiopulmonary Exercise Testing in Patients With Fontan Circulation.
    J Am Coll Cardiol. 2023;81:1601-1604.
    PubMed    


    March 2023
  59. TRUESDELL AG, Mehta A, Cilia LA
    Myocardial Infarction, Cardiogenic Shock, and Cardiac Arrest: Management Made Simple, But Not Too Simple.
    J Am Coll Cardiol. 2023;81:1177-1180.
    PubMed    


  60. ZEYMER U, Alushi B, Noc M, Mamas MA, et al
    Influence of Culprit Lesion Intervention on Outcomes in Infarct-Related Cardiogenic Shock With Cardiac Arrest.
    J Am Coll Cardiol. 2023;81:1165-1176.
    PubMed     Abstract available


    February 2023
  61. TU S, Xu B, Chen L, Hong H, et al
    Short-Term Risk Stratification of Non-Flow-Limiting Coronary Stenosis by Angiographically Derived Radial Wall Strain.
    J Am Coll Cardiol. 2023;81:756-767.
    PubMed     Abstract available


  62. FLATHER M, Talukder S
    Saphenous Vein Grafts for Coronary Surgery: More May Be Less.
    J Am Coll Cardiol. 2023;81:726-728.
    PubMed    


  63. SHIH E, Squiers JJ, Banwait JK, Mack MJ, et al
    Vein Graft Use and Long-Term Survival Following Coronary Bypass Grafting.
    J Am Coll Cardiol. 2023;81:713-725.
    PubMed     Abstract available


  64. TRUESDELL AG, Alasnag MA, Kaul P, Rab ST, et al
    Intravascular Imaging During Percutaneous Coronary Intervention: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2023;81:590-605.
    PubMed     Abstract available


  65. BHATT DL
    Optimal Antiplatelet Therapy Revisited: When Is a Single Better Than a Double?
    J Am Coll Cardiol. 2023;81:553-556.
    PubMed    


  66. GRAGNANO F, Mehran R, Branca M, Franzone A, et al
    P2Y(12) Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions.
    J Am Coll Cardiol. 2023;81:537-552.
    PubMed     Abstract available


  67. KERN KB
    Timely Reperfusion for Everyone...Except for Some Out-of-Hospital Cardiac Arrest Patients?
    J Am Coll Cardiol. 2023;81:457-459.
    PubMed    


  68. SPIRITO A, Vaisnora L, Papadis A, Iacovelli F, et al
    Acute Coronary Occlusion in Patients With Non-ST-Segment Elevation Out-of-Hospital Cardiac Arrest.
    J Am Coll Cardiol. 2023;81:446-456.
    PubMed     Abstract available


    January 2023
  69. LIN J, Lluri G
    Thromboprophylaxis in the Fontan Circulation: Long-Awaited Validation.
    J Am Coll Cardiol. 2023;81:390-393.
    PubMed    


  70. VAN DEN EYNDE J, Possner M, Alahdab F, Veldtman G, et al
    Thromboprophylaxis in Patients With Fontan Circulation.
    J Am Coll Cardiol. 2023;81:374-389.
    PubMed     Abstract available


  71. BONACA MP, Hogan SE
    Tradeoffs in Approach to PAD Revascularization: Shared Decision Making in the Spotlight.
    J Am Coll Cardiol. 2023;81:371-373.
    PubMed    


  72. FARHAN S, Enzmann FK, Bjorkman P, Kamran H, et al
    Revascularization Strategies for Patients With Femoropopliteal Peripheral Artery Disease.
    J Am Coll Cardiol. 2023;81:358-370.
    PubMed     Abstract available


  73. FELDMAN DN, Klein AJP
    Drug-Coated Balloons in Peripheral Vascular Interventions: Leave No Trace and Walk Away?
    J Am Coll Cardiol. 2023;81:250-252.
    PubMed    


  74. SHISHEHBOR MH, Scheinert D, Jain A, Brodmann M, et al
    Comparison of Drug-Coated Balloons vs Bare-Metal Stents in Patients With Femoropopliteal Arterial Disease.
    J Am Coll Cardiol. 2023;81:237-249.
    PubMed     Abstract available


  75. DHAUN N, Pugh D, Youngstein T
    Percutaneous Intervention in Takayasu Arteritis: Potential Advantages of Procedural Perseverance.
    J Am Coll Cardiol. 2023;81:65-67.
    PubMed    


  76. JOSEPH G, Thomson VS, Attumalil TV, Mathen PG, et al
    Outcomes of Percutaneous Intervention in Patients With Takayasu Arteritis.
    J Am Coll Cardiol. 2023;81:49-64.
    PubMed     Abstract available


    November 2022
  77. SONG L, Xu B, Tu S, Guan C, et al
    2-Year Outcomes of Angiographic Quantitative Flow Ratio-Guided Coronary Interventions.
    J Am Coll Cardiol. 2022;80:2089-2101.
    PubMed     Abstract available


  78. DAVIDSON LJ, Cleveland JC, Welt FG, Anwaruddin S, et al
    A Practical Approach to Left Main Coronary Artery Disease: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;80:2119-2134.
    PubMed     Abstract available


  79. ROYSE A, Ren J, Royse C, Tian DH, et al
    Coronary Artery Bypass Surgery Without Saphenous Vein Grafting: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;80:1833-1843.
    PubMed     Abstract available


  80. TARDIF JC, Thorin E
    Inhibition of the Mechanistic Target of Rapamycin in Acute Myocardial Infarction.
    J Am Coll Cardiol. 2022;80:1815-1817.
    PubMed    


  81. NICHOL G, West A
    Contemporary Approaches to Reducing Morbidity and Mortality in Patients With Acute Coronary Syndromes.
    J Am Coll Cardiol. 2022;80:1799-1801.
    PubMed    


  82. GONG W, Yan Y, Wang X, Zheng W, et al
    Risk Factors for In-Hospital Cardiac Arrest in Patients With ST-Segment Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2022;80:1788-1798.
    PubMed     Abstract available


  83. KORJIAN S, Yeh RW, Cutlip DE
    Ischemic Risk Prediction Scores: Practice-Changing or Just Practice?
    J Am Coll Cardiol. 2022;80:1748-1750.
    PubMed    


  84. BATRA G, Lindback J, Becker RC, Harrington RA, et al
    Biomarker-Based Prediction of Recurrent Ischemic Events in Patients With Acute Coronary Syndromes.
    J Am Coll Cardiol. 2022;80:1735-1747.
    PubMed     Abstract available


    October 2022
  85. BOHME M, Desch S, Rosolowski M, Scholz M, et al
    Impact of Clonal Hematopoiesis in Patients With Cardiogenic Shock Complicating Acute Myocardial Infarction.
    J Am Coll Cardiol. 2022;80:1545-1556.
    PubMed     Abstract available


    September 2022
  86. JIN Z, Xu B, Yang X, Jia R, et al
    Coronary Intervention Guided by Quantitative Flow Ratio vs Angiography in Patients With or Without Diabetes.
    J Am Coll Cardiol. 2022;80:1254-1264.
    PubMed     Abstract available


  87. SATTAR Y, Aronow HD, Alam M
    Drug-Coated Balloon Failure Following Femoro-Popliteal Intervention: Where to Draw the Line?
    J Am Coll Cardiol. 2022;80:1251-1253.
    PubMed    


  88. KRISHNAN P, Farhan S, Schneider P, Kamran H, et al
    Determinants of Drug-Coated Balloon Failure in Patients Undergoing Femoropopliteal Arterial Intervention.
    J Am Coll Cardiol. 2022;80:1241-1250.
    PubMed     Abstract available


  89. KINLAY S
    Post-PCI Antithrombotic Treatment With High Bleeding Risk.
    J Am Coll Cardiol. 2022;80:1238-1240.
    PubMed    


  90. SMITS PC, Frigoli E, Vranckx P, Ozaki Y, et al
    Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding Risk.
    J Am Coll Cardiol. 2022;80:1220-1237.
    PubMed     Abstract available


    August 2022
  91. FAGUNDES A JR, Morrow DA, Oyama K, Furtado RHM, et al
    Biomarker Prediction of Complex Coronary Revascularization Procedures in the FOURIER Trial.
    J Am Coll Cardiol. 2022;80:887-897.
    PubMed     Abstract available


  92. STAHLI BE, Klingenberg R, Heg D, Branca M, et al
    Randomized Trial of Early mTOR Inhibition in Patients with Acute ST-Segment Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2022 Aug 24. pii: S0735-1097(22)06613.
    PubMed     Abstract available


  93. OUZOUNIAN M, Tadros RO, Svensson LG, Lyden SP, et al
    Thoracoabdominal Aortic Disease and Repair: JACC Focus Seminar, Part 3.
    J Am Coll Cardiol. 2022;80:845-856.
    PubMed     Abstract available


  94. HENSLEY SE, Upchurch GR Jr
    Repair of Abdominal Aortic Aneurysms: JACC Focus Seminar, Part 1.
    J Am Coll Cardiol. 2022;80:821-831.
    PubMed     Abstract available


  95. VALGIMIGLI M, Frigoli E, Vranckx P, Ozaki Y, et al
    Impact of Medication Nonadherence in a Clinical Trial of Dual Antiplatelet Therapy.
    J Am Coll Cardiol. 2022;80:766-778.
    PubMed     Abstract available


    July 2022
  96. GIUSTINO G, Colombo A, Camaj A, Yasumura K, et al
    Coronary In-Stent Restenosis: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;80:348-372.
    PubMed     Abstract available


    June 2022
  97. EVANGELISTA A, Pineda V, Guala A, Bijnens B, et al
    False Lumen Flow Assessment by Magnetic Resonance Imaging and Long-Term Outcomes in Uncomplicated Aortic Dissection.
    J Am Coll Cardiol. 2022;79:2415-2427.
    PubMed     Abstract available


  98. VERDOIA M, Gioscia R, Rognoni A
    Updates on the Management of STEMI in 2021: Beyond COVID-19.
    J Am Coll Cardiol. 2022;79:2245-2246.
    PubMed    


  99. GARCIA S, Dehghani P, Stanberry L, Grines C, et al
    Trends in Clinical Presentation, Management, and Outcomes of STEMI in Patients With COVID-19.
    J Am Coll Cardiol. 2022;79:2236-2244.
    PubMed     Abstract available


    May 2022
  100. RAJKUMAR CA, Wereski R, Parsonage W, Cullen L, et al
    Association Between High-Sensitivity Cardiac Troponin, Myocardial Ischemia, and Revascularization in Stable Coronary Artery Disease.
    J Am Coll Cardiol. 2022;79:2185-2187.
    PubMed    


  101. DORFMAN AL, Del Nido PJ
    The Right Ventricle and Tricuspid Valve in Fontan Failure: A Role for Early Surgical Management.
    J Am Coll Cardiol. 2022;79:1846-1848.
    PubMed    


  102. KING G, Buratto E, Celermajer DS, Grigg L, et al
    Natural and Modified History of Atrioventricular Valve Regurgitation in Patients With Fontan Circulation.
    J Am Coll Cardiol. 2022;79:1832-1845.
    PubMed     Abstract available


  103. SHERRID MV, Massera D, Swistel DG
    Surgical Septal Myectomy and Alcohol Ablation: Not Equivalent in Efficacy or Survival.
    J Am Coll Cardiol. 2022;79:1656-1659.
    PubMed    


  104. CUI H, Schaff HV, Wang S, Lahr BD, et al
    Survival Following Alcohol Septal Ablation or Septal Myectomy for Patients With Obstructive Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2022;79:1647-1655.
    PubMed     Abstract available


    April 2022
  105. OLIN JW, Johnston-Cox H
    Angioplasty to Treat Pulmonary Hypertension in Takayasu Arteritis: An Uncommon Treatment for an Uncommon Disease.
    J Am Coll Cardiol. 2022;79:1489-1491.
    PubMed    


  106. ZHOU YP, Wei YP, Yang YJ, Xu XQ, et al
    Percutaneous Pulmonary Angioplasty for Patients With Takayasu Arteritis and Pulmonary Hypertension.
    J Am Coll Cardiol. 2022;79:1477-1488.
    PubMed     Abstract available


  107. GRANGER CB, Krychtiuk KA, Gersh BJ
    Personalizing Choice of CABG vs PCI for Multivessel Disease: Predictive Model Falls Short.
    J Am Coll Cardiol. 2022;79:1474-1476.
    PubMed    


  108. TAKAHASHI K, Serruys PW, Fuster V, Farkouh ME, et al
    External Validation of the FREEDOM Score for Individualized Decision Making Between CABG and PCI.
    J Am Coll Cardiol. 2022;79:1458-1473.
    PubMed     Abstract available


  109. GAUDINO M, Di Franco A, Cao D, Giustino G, et al
    Sex-Related Outcomes of Medical, Percutaneous, and Surgical Interventions for Coronary Artery Disease: JACC Focus Seminar 3/7.
    J Am Coll Cardiol. 2022;79:1407-1425.
    PubMed     Abstract available


  110. MEHRAN R, Cao D, Vogel B
    Rethinking the Role of Impaired Renal Function in Multivessel PCI or CABG.
    J Am Coll Cardiol. 2022;79:1285-1287.
    PubMed    


  111. KIM TO, Kang DY, Ahn JM, Kim SO, et al
    Prognostic Impact of Mildly Impaired Renal Function in Patients Undergoing Multivessel Coronary Revascularization.
    J Am Coll Cardiol. 2022;79:1270-1284.
    PubMed     Abstract available


    March 2022
  112. KWONG RY, Cardoso R, Jerosch-Herold M
    Quantitative CMR Perfusion in Patients After CABG: Emerging and Promising Evidence.
    J Am Coll Cardiol. 2022;79:1152-1154.
    PubMed    


  113. WONG CCY, Yong ASC, Keech A, Ada C, et al
    Evolution of the Coronary Microcirculation After Restoration of Epicardial Blood Flow in STEMI.
    J Am Coll Cardiol. 2022;79:1127-1128.
    PubMed    


  114. GOTBERG M, Berntorp K, Rylance R, Christiansen EH, et al
    5-Year Outcomes of PCI Guided by Measurement of Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve.
    J Am Coll Cardiol. 2022;79:965-974.
    PubMed     Abstract available


    February 2022
  115. MCCARTHY CP, Januzzi JL Jr
    Periprocedural MI as an Endpoint in Clinical Trials: A Proposed Path Forward.
    J Am Coll Cardiol. 2022;79:527-529.
    PubMed    


  116. UEKI Y, Otsuka T, Bar S, Koskinas KC, et al
    Frequency and Outcomes of Periprocedural MI in Patients With Chronic Coronary Syndromes Undergoing PCI.
    J Am Coll Cardiol. 2022;79:513-526.
    PubMed     Abstract available


  117. VRANCKX P, Angiolillo DJ, Valgimigli M
    Patients With Atrial Fibrillation and PCI or ACS: Does Predicted Risk Matter?
    J Am Coll Cardiol. 2022;79:428-431.
    PubMed    


  118. HARSKAMP RE, Fanaroff AC, Lopes RD, Wojdyla DM, et al
    Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous Intervention.
    J Am Coll Cardiol. 2022;79:417-427.
    PubMed     Abstract available


    January 2022
  119. LOCCOH EC, Joynt Maddox KE, Wang Y, Kazi DS, et al
    Rural-Urban Disparities in Outcomes of Myocardial Infarction, Heart Failure, and Stroke in the United States.
    J Am Coll Cardiol. 2022;79:267-279.
    PubMed     Abstract available


  120. HAN Y, Liao Z, Li Y, Zhao X, et al
    Magnetically Controlled Capsule Endoscopy for Assessment of Antiplatelet Therapy-Induced Gastrointestinal Injury.
    J Am Coll Cardiol. 2022;79:116-128.
    PubMed     Abstract available


  121. LIU T, Howarth AG, Chen Y, Nair AR, et al
    Intramyocardial Hemorrhage and the "Wave Front" of Reperfusion Injury Compromising Myocardial Salvage.
    J Am Coll Cardiol. 2022;79:35-48.
    PubMed     Abstract available


    December 2021
  122. GRINES CL, Marshall JJ
    Early Discharge After ST-Segment Elevation Myocardial Infarction: The Days Are Getting Shorter!
    J Am Coll Cardiol. 2021;78:2561-2562.
    PubMed    


  123. RATHOD KS, Comer K, Casey-Gillman O, Moore L, et al
    Early Hospital Discharge Following PCI for Patients With STEMI.
    J Am Coll Cardiol. 2021;78:2550-2560.
    PubMed     Abstract available


    November 2021
  124. NATHAN AS, Manandhar P, Wojdyla D, Nelson A, et al
    Hospital-Level Percutaneous Coronary Intervention Performance With Simulated Risk Avoidance.
    J Am Coll Cardiol. 2021;78:2213-2217.
    PubMed    


  125. GIRI J, Fanaroff AC
    1 Month of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention: The New Standard?
    J Am Coll Cardiol. 2021;78:2073-2075.
    PubMed    


  126. HARRIS KM, Mena-Hurtado C, Arham A, Burg MM, et al
    Increasing Prevalence of Critical Limb Ischemia Hospitalizations With Distinct Mental Health Burden Among Younger Adults.
    J Am Coll Cardiol. 2021;78:2126-2128.
    PubMed    


  127. VALGIMIGLI M, Cao D, Angiolillo DJ, Bangalore S, et al
    Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI.
    J Am Coll Cardiol. 2021;78:2060-2072.
    PubMed     Abstract available


  128. PARIKH PB
    Dual Antiplatelet Duration After DES: Is it Time to Say Goodbye to 1-Year DAPT?
    J Am Coll Cardiol. 2021;78:1987-1989.
    PubMed    


  129. DAVIDSON BP, Hodovan J, Layoun ME, Golwala H, et al
    Echocardiographic Ischemic Memory Molecular Imaging for Point-of-Care Detection of Myocardial Ischemia.
    J Am Coll Cardiol. 2021;78:1990-2000.
    PubMed     Abstract available


  130. RIOUFOL G, Derimay F, Roubille F, Perret T, et al
    Fractional Flow Reserve to Guide Treatment of Patients With Multivessel Coronary Artery Disease.
    J Am Coll Cardiol. 2021;78:1875-1885.
    PubMed     Abstract available


  131. ZELLER T, Bohme T
    Antiproliferative Device Coatings: Efficacy Without Adverse Drug Effect?
    J Am Coll Cardiol. 2021;78:1779-1781.
    PubMed    


  132. HESS CN, Patel MR, Bauersachs RM, Anand SS, et al
    Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery Revascularization: Insights From VOYAGER PAD.
    J Am Coll Cardiol. 2021;78:1768-1778.
    PubMed     Abstract available


    October 2021
  133. METKUS TS, Grant MC, Zwischenberger B, Higgins R, et al
    Reply: When Will We Stop Debating on the Value of TEE in CABG?
    J Am Coll Cardiol. 2021;78:e139-e140.
    PubMed    


  134. ZHAN Y, Brovman EY, Cobey F
    When Will We Stop Debating on the Value of TEE in CABG?
    J Am Coll Cardiol. 2021;78:e137.
    PubMed    


  135. SULLIVAN AE, Nanna MG, Wang TY, Bhatt DL, et al
    Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2021;78:1550-1563.
    PubMed     Abstract available


  136. AN KR, de Mestral C, Tam DY, Qiu F, et al
    Surveillance Imaging Following Acute Type A Aortic Dissection.
    J Am Coll Cardiol. 2021 Oct 5. pii: S0735-1097(21)06218.
    PubMed     Abstract available


    September 2021
  137. GUO MH, Vo TX, Horsthuis K, Rahmouni K, et al
    Durability of Minimally Invasive Coronary Artery Bypass Grafting.
    J Am Coll Cardiol. 2021;78:1390-1391.
    PubMed    


  138. KASTRATI A, Coughlan JJ, Ndrepepa G
    Primary PCI, Late Presenting STEMI, and the Limits of Time.
    J Am Coll Cardiol. 2021;78:1306-1308.
    PubMed    


  139. BOUISSET F, Gerbaud E, Bataille V, Coste P, et al
    Percutaneous Myocardial Revascularization in Late-Presenting Patients With STEMI.
    J Am Coll Cardiol. 2021;78:1291-1305.
    PubMed     Abstract available


  140. SQUIERS JJ, DiMaio JM
    SYNTAX Score II 2020: A Remake Worth the Price of Admission?
    J Am Coll Cardiol. 2021;78:1239-1241.
    PubMed    


  141. HARA H, Shiomi H, van Klaveren D, Kent DM, et al
    External Validation of the SYNTAX Score II 2020.
    J Am Coll Cardiol. 2021;78:1227-1238.
    PubMed     Abstract available


    August 2021
  142. WU EB, Brilakis ES, Mashayekhi K, Tsuchikane E, et al
    Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;78:840-853.
    PubMed     Abstract available


  143. HSIA J, Szarek M, Anand S, Patel MR, et al
    Rivaroxaban in Patients With Recent Peripheral Artery Revascularization and Renal Impairment: The VOYAGER PAD Trial.
    J Am Coll Cardiol. 2021;78:757-759.
    PubMed    


  144. GRADY RM, Canter MW, Wan F, Shmalts AA, et al
    Pulmonary-to-Systemic Arterial Shunt to Treat Children With Severe Pulmonary Hypertension.
    J Am Coll Cardiol. 2021;78:468-477.
    PubMed     Abstract available


    July 2021
  145. SERRUYS PW, Ono M, Garg S, Hara H, et al
    Percutaneous Coronary Revascularization: JACC Historical Breakthroughs in Perspective.
    J Am Coll Cardiol. 2021;78:384-407.
    PubMed     Abstract available


  146. BRENER SJ
    Refinements in Predicting In-Hospital Mortality Following PCI: The Science and Art of Competing Risk Analysis.
    J Am Coll Cardiol. 2021;78:230-233.
    PubMed    


  147. SONNY A, Joseph L
    Improving CABG Mortality Further: Striving Toward Perfection.
    J Am Coll Cardiol. 2021;78:123-125.
    PubMed    


  148. DOENST T, Bonow RO, Bhatt DL, Falk V, et al
    Improving Terminology to Describe Coronary Artery Procedures: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2021;78:180-188.
    PubMed     Abstract available


  149. BODEN WE, Gersh BJ
    Defining the Proper SYNTAX for Long-Term Benefit of Myocardial Revascularization With Optimal Medical Therapy.
    J Am Coll Cardiol. 2021;78:39-41.
    PubMed    


  150. KAWASHIMA H, Serruys PW, Ono M, Hara H, et al
    Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization.
    J Am Coll Cardiol. 2021;78:27-38.
    PubMed     Abstract available


    June 2021
  151. ZALEWSKI PD, Tvorogova Z, Abdo A, Wawer AA, et al
    Harvesting Endothelial Cells During Routine Invasive Coronary Procedures.
    J Am Coll Cardiol. 2021;77:3136-3138.
    PubMed    


  152. BARTHELEMY O, Rouanet S, Zeymer U, Thiele H, et al
    Reply: The Residual SYNTAX Score: A Useful Tool to Predict Outcomes in Cardiogenic Shock.
    J Am Coll Cardiol. 2021;77:2872-2873.
    PubMed    


  153. LI X, Ni S
    Could Residual SYNTAX Score Predict the Prognosis of Patients With Cardiogenic Shock?
    J Am Coll Cardiol. 2021;77:2872.
    PubMed    


  154. BURGESS SN, Juergens CP, Mussap CJ, Lo STH, et al
    Cardiogenic Shock, the Residual SYNTAX Score, and Prognosis: Corroborative "Real-World" Data.
    J Am Coll Cardiol. 2021;77:2871-2872.
    PubMed    


  155. HESS CN, Fu JW, Gundrum J, Allen LaPointe NM, et al
    Diabetes Mellitus and Risk Stratification After Peripheral Artery Revascularization.
    J Am Coll Cardiol. 2021;77:2867-2869.
    PubMed    


  156. HIRA RS
    Revascularizing Complex CAD in Elderly Patients: The Coming-of-Age Story of Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2021;77:2774-2776.
    PubMed    


  157. ONO M, Serruys PW, Hara H, Kawashima H, et al
    10-Year Follow-Up After Revascularization in Elderly Patients With Complex Coronary Artery Disease.
    J Am Coll Cardiol. 2021;77:2761-2773.
    PubMed     Abstract available


    May 2021
  158. FOGEL MA
    The Fontan: "Straining" to Understand That "The Bigger They Come, The Harder They Fall".
    J Am Coll Cardiol. 2021;77:2490-2493.
    PubMed    


  159. MEYER SL, St Clair N, Powell AJ, Geva T, et al
    Integrated Clinical and Magnetic Resonance Imaging Assessments Late After Fontan Operation.
    J Am Coll Cardiol. 2021;77:2480-2489.
    PubMed     Abstract available


  160. ALVAREZ-FUENTE M, Ayala A, Garrido-Lestache E, Bermudez-Canete R, et al
    Long-Term Complications After Aortic Coarctation Stenting.
    J Am Coll Cardiol. 2021;77:2448-2450.
    PubMed    


  161. PARIKH PB, Bhatt DL, Bhasin V, Anker SD, et al
    Impact of Percutaneous Coronary Intervention on Outcomes in Patients With Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:2432-2447.
    PubMed     Abstract available


  162. MARLEVI D, Edelman ER
    Vascular Lesion-Specific Drug Delivery Systems: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:2413-2431.
    PubMed     Abstract available


  163. LEITER LA, Bhatt DL, McGuire DK, Teoh H, et al
    Diabetes-Related Factors and the Effects of Ticagrelor Plus Aspirin in the THEMIS and THEMIS-PCI Trials.
    J Am Coll Cardiol. 2021;77:2366-2377.
    PubMed     Abstract available


  164. BAUERSACHS RM, Szarek M, Brodmann M, Gudz I, et al
    Total Ischemic Event Reduction with Rivaroxaban after Peripheral Arterial Revascularization in the VOYAGER PAD Trial.
    J Am Coll Cardiol. 2021 May 7. pii: S0735-1097(21)05016.
    PubMed     Abstract available


  165. VINCIGUERRA M, Spadaccio C, Tennyson C, Karuppannan M, et al
    Management of Patients With Aortocoronary Saphenous Vein Graft Aneurysms: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:2236-2253.
    PubMed     Abstract available


  166. FAROUX L, Lhermusier T, Vincent F, Nombela-Franco L, et al
    ST-Segment Elevation Myocardial Infarction Following Transcatheter Aortic Valve Replacement.
    J Am Coll Cardiol. 2021;77:2187-2199.
    PubMed     Abstract available


    April 2021
  167. METKUS TS, Thibault D, Grant MC, Badhwar V, et al
    Utilization and outcomes of transesophageal echocardiography in 1.3 million CABG procedures.
    J Am Coll Cardiol. 2021 Apr 28. pii: S0735-1097(21)04930.
    PubMed     Abstract available


  168. CASTRO-DOMINGUEZ YS, Wang Y, Minges KE, McNamara RL, et al
    Predicting In-Hospital Mortality in Patients Undergoing Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2021 Apr 28. pii: S0735-1097(21)04934.
    PubMed     Abstract available


  169. GARCIA S, Dehghani P, Grines C, Davidson L, et al
    Initial Findings From the North American COVID-19 Myocardial Infarction Registry.
    J Am Coll Cardiol. 2021;77:1994-2003.
    PubMed     Abstract available


  170. YAMMINE H, Briggs CS, Rolle QV, Ballast JK, et al
    Simultaneous Transcatheter Aortic Valve Replacement and Endovascular Aortic Aneurysm Repair.
    J Am Coll Cardiol. 2021;77:2156-2157.
    PubMed    


  171. TANG GHL, Tadros RO
    Endovascular Aortic Repair in Nonagenarians: Select Well and Time Appropriately.
    J Am Coll Cardiol. 2021;77:1900-1902.
    PubMed    


  172. PRENDES CF, Dayama A, Panneton JM, Stana J, et al
    Endovascular Aortic Repair in Nonagenarian Patients.
    J Am Coll Cardiol. 2021;77:1891-1899.
    PubMed     Abstract available


  173. CHO KH, Han X, Ahn JH, Hyun DY, et al
    Long-Term Outcomes of Patients With Late Presentation of ST-Segment Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2021;77:1859-1870.
    PubMed     Abstract available


  174. RIDKER PM
    Inhibiting Interleukin-6 to Reduce Cardiovascular Event Rates: A Next Step for Atherothrombosis Treatment and Prevention.
    J Am Coll Cardiol. 2021;77:1856-1858.
    PubMed    


  175. BROCH K, Anstensrud AK, Woxholt S, Sharma K, et al
    Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2021;77:1845-1855.
    PubMed     Abstract available


  176. PERICAS JM, Llopis J, Jimenez-Exposito MJ, Kourany WM, et al
    Infective Endocarditis in Patients on Chronic Hemodialysis.
    J Am Coll Cardiol. 2021;77:1629-1640.
    PubMed     Abstract available


    March 2021
  177. EGBE AC, Borlaug BA
    Reply: Abnormal Pulmonary Vascular Reserve in Fontan: Pulmonary Vascular Disease Versus Diastolic Dysfunction.
    J Am Coll Cardiol. 2021;77:1596-1597.
    PubMed    


  178. CEDARS A, Opotowsky A, Tedford RJ, Burkhoff D, et al
    Resist Neglecting Diastolic Dysfunction in Fontan Physiology.
    J Am Coll Cardiol. 2021;77:1595-1596.
    PubMed    


  179. LATUS H, Apitz C
    Exercise-Induced Pulmonary Hypertension: The Final Answer to Characterize Pulmonary Vascular Disease in Fontan Patients?
    J Am Coll Cardiol. 2021;77:1594-1595.
    PubMed    


  180. SABA PS, Parodi G, Ganau A
    From Risk Factors to Clinical Disease: New Opportunities and Challenges for Cardiovascular Risk Prediction.
    J Am Coll Cardiol. 2021;77:1436-1438.
    PubMed    


  181. VANDERHEYDEN M, Bartunek J, Neskovic AN, Milicic D, et al
    TRVD Therapy in Acute HF: Proof of Concept in Animal Model and Initial Clinical Experience.
    J Am Coll Cardiol. 2021;77:1481-1483.
    PubMed    


  182. LLANOS-CHEA F, Jelani QU, Trejo-Paredes C, Curtis JP, et al
    Lack of Guideline-Directed Medical Therapy in Patients Undergoing Endovascular Procedures for Critical Limb Ischemia.
    J Am Coll Cardiol. 2021;77:1374-1375.
    PubMed    


  183. NAKASHIMA CAK, Dallan LAO, Lisboa LAF, Jatene FB, et al
    Platelet Reactivity in Patients With Acute Coronary Syndromes Awaiting Surgical Revascularization.
    J Am Coll Cardiol. 2021;77:1277-1286.
    PubMed     Abstract available


  184. CUTLIP DE
    Standing the Test of Time: A Device and Patient Perspective.
    J Am Coll Cardiol. 2021;77:1179-1181.
    PubMed    


    February 2021
  185. MCCARTHY CP, Kolte D, Kennedy KF, Vaduganathan M, et al
    Patient Characteristics and Clinical Outcomes of Type 1 Versus Type 2 Myocardial Infarction.
    J Am Coll Cardiol. 2021;77:848-857.
    PubMed     Abstract available


  186. KRAWISZ AK, Rosenfield K, White CJ, Jaff MR, et al
    Clinical Impact of Contralateral Carotid Occlusion in Patients Undergoing Carotid Artery Revascularization.
    J Am Coll Cardiol. 2021;77:835-844.
    PubMed     Abstract available


  187. MOSES JW, Prasad M
    Are All Total Occlusions Created Equal?: Striving for Complete Revascularization While Differentiating Apples From Oranges.
    J Am Coll Cardiol. 2021;77:541-543.
    PubMed    


  188. KAWASHIMA H, Takahashi K, Ono M, Hara H, et al
    Mortality 10 Years After Percutaneous or Surgical Revascularization in Patients With Total Coronary Artery Occlusions.
    J Am Coll Cardiol. 2021;77:529-540.
    PubMed     Abstract available


  189. KODALI S, Hahn RT, Eleid MF, Kipperman R, et al
    Feasibility Study of the Transcatheter Valve Repair System for Severe Tricuspid Regurgitation.
    J Am Coll Cardiol. 2021;77:345-356.
    PubMed     Abstract available


    January 2021
  190. OHMAN EM, Nanna MG
    Cholesterol Lowering and Coronary Revascularization: Finally a Marriage to Sustain?
    J Am Coll Cardiol. 2021;77:268-270.
    PubMed    


  191. LURZ P, Stephan von Bardeleben R, Weber M, Sitges M, et al
    Transcatheter Edge-to-Edge Repair for Treatment of Tricuspid Regurgitation.
    J Am Coll Cardiol. 2021;77:229-239.
    PubMed     Abstract available


  192. KOCHAR A, Varshney AS, Wang DE
    Residual SYNTAX Score After Revascularization in Cardiogenic Shock: When Is Complete Complete?
    J Am Coll Cardiol. 2021;77:156-158.
    PubMed    


  193. BARTHELEMY O, Rouanet S, Brugier D, Vignolles N, et al
    Predictive Value of the Residual SYNTAX Score in Patients With Cardiogenic Shock.
    J Am Coll Cardiol. 2021;77:144-155.
    PubMed     Abstract available


  194. LAWTON JS
    Why Not Give All Patients the Opportunity to Have the Benefits of BITA Grafting?
    J Am Coll Cardiol. 2021;77:27-28.
    PubMed    


  195. GOLDSTEIN BH, Kreutzer J
    Transcatheter Intervention for Congenital Defects Involving the Great Vessels: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2021;77:80-96.
    PubMed     Abstract available


  196. WANG H, Zhang Y, Xin F, Jiang H, et al
    Calcium-Induced Autonomic Denervation in Patients With Post-Operative Atrial Fibrillation.
    J Am Coll Cardiol. 2021;77:57-67.
    PubMed     Abstract available


  197. GAUDINO M, Di Franco A, Flather M, Gerry S, et al
    Association of Age With 10-Year Outcomes After Coronary Surgery in the Arterial Revascularization Trial.
    J Am Coll Cardiol. 2021;77:18-26.
    PubMed     Abstract available


    December 2020
  198. RAO SV, Vidovich MI, Gilchrist IC, Gulati R, et al
    2021 ACC Expert Consensus Decision Pathway on Same-Day Discharge After Percutaneous Coronary Intervention: A Report of the American College of Cardiology Solution Set Oversight Committee.
    J Am Coll Cardiol. 2020 Dec 28. pii: S0735-1097(20)37778.
    PubMed    


    November 2020
  199. KUMBHANI DJ, Cannon CP, Beavers CJ, Bhatt DL, et al
    2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Report
    J Am Coll Cardiol. 2020 Nov 26. pii: S0735-1097(20)36615.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Vascular Surgery is free of charge.